Latest News for: respiratory tract infection

Edit

Zinc might help to stave off respiratory infection symptoms and cut illness duration

Mega Doctor News 04 Nov 2021
Newswise — A zinc supplement might help stave off the symptoms of respiratory tract infections, such as coughing, congestion, and sore throat, and cut illness duration, suggests a pooled analysis of the available evidence, published in the open access journal BMJ Open.
Edit

Zinc supplements may help reduce symptoms of respiratory infections: Study

Indian Express 04 Nov 2021
Zinc supplements may help stave off the symptoms of respiratory tract infections such as coughing, congestion and sore throat, and cut illness duration, according to a review of studies ... Respiratory tract infections include colds, flu, sinusitis, pneumonia, and COVID-19.
Edit

McCaughey: New vaccine science shows mandates are unwise

Longview News-Journal 04 Nov 2021
The key word is “choose.” Though shots are no guarantee against getting infected and spreading it to others, they provide significant protection (90% or more) against hospitalization and death ... The vaccinated had just as much viral load in their upper respiratory tract, making them just as contagious.
Edit

Seven places named in compulsory testing notice, including six schools

Hong Kong Standard 04 Nov 2021
In the compulsory testing notices released last night, people who visited the cold storage are included in the notice.  ... The Standard Channel. IOS Android. IOS Android. More>>.; Meanwhile, six schools have also been named in the notices due to outbreaks of upper respiratory tract infection and influenza-like illness.  ...  . .
Edit

Bristol Myers Squibb to Highlight More than 80 Abstracts at ASH 2021 Demonstrating Strength of ...

The Marshall News Messenger 04 Nov 2021
The most common nonlaboratory adverse reactions (incidence greater than or equal to 20%) include CRS, infections – pathogen unspecified, fatigue, musculoskeletal pain, hypogammaglobulinemia, diarrhea, upper respiratory tract infection, nausea, viral infections, encephalopathy, edema, pyrexia, cough, headache, and decreased appetite.
Edit

Karyopharm Announces New Interim Phase 2 Selinexor Data in Myelofibrosis Selected for Oral Presentation at ...

Daily Times Chronicle 04 Nov 2021
Adverse ReactionsThe most common adverse reactions (≥20%) in patients with multiple myeloma who receive XVd are fatigue, nausea, decreased appetite, diarrhea, peripheral neuropathy, upper respiratory tract infection, decreased weight, cataract and vomiting ... tract infection.
Edit

Janssen to Present the Strength and Promise of its Hematologic Malignancies Portfolio and Pipeline at ...

Johnson City Press 04 Nov 2021
In multiple myeloma, the most common adverse reaction (≥20%) with DARZALEX FASPRO® monotherapy is upper respiratory tract infection ... pyrexia, cough, muscle spasms, back pain, vomiting, upper respiratory tract infection, peripheral sensory neuropathy, constipation, and pneumonia.
Edit

AbbVie to Highlight New Advances in Blood Cancer Research and Expanding Oncology Pipeline at 63rd ...

News-Press Now 04 Nov 2021
The most common side effects of VENCLEXTA when used in combination with obinutuzumab or rituximab or alone in people with CLL or SLL include low white blood cell counts; low platelet counts; low red blood cell counts; diarrhea; nausea; upper respiratory tract infection; cough; ...
Edit

Ironwood Pharmaceuticals Expands Pipeline by Signing an Option Agreement to Acquire an Exclusive License with ...

The Marshall News Messenger 04 Nov 2021
BOSTON--(BUSINESS WIRE)--Nov 4, 2021--. (NASDAQ ... (“COUR”), a biotechnology company developing novel immune-modifying nanoparticles to treat autoimmune diseases ... WARNING ... diarrhea (16% vs 5% placebo), abdominal pain (7% vs 6%), flatulence (6% vs 5%), upper respiratory tract infection (5% vs 4%), sinusitis (3% vs 2%) and abdominal distension (3% vs 2%).
Edit

Ironwood Pharmaceuticals Reports Third Quarter 2021 Results and Provides Corporate Development Update

Pharmiweb 04 Nov 2021
– LINZESS® (Iinaclotide) prescription demand growth increased 12% year-over-year; LINZESS U.S. net sales of $253 million, an increase of 5% year-over-year – ... (Nasdaq ... diarrhea (16% vs 5% placebo), abdominal pain (7% vs 6%), flatulence (6% vs 5%), upper respiratory tract infection (5% vs 4%), sinusitis (3% vs 2%) and abdominal distension (3% vs 2%) ... .
Edit

Q&A;: is the common cold really much worse this year?

The Conversation 03 Nov 2021
These viruses typically consist of several strains that circulate seasonally, are more common in winter and usually infect the upper respiratory tract ... From early 2020, it was clear that these measures also reduced transmission of other respiratory infections .
Edit

Bristol Myers Squibb Data at ACR Convergence 2021 Illustrate Scientific Advances for Immune-Mediated Rheumatic Diseases

The Marshall News Messenger 03 Nov 2021
Infections. Serious infections, including sepsis and pneumonia, were reported in 3% and 1.9% of RA patients treated with intravenous ORENCIA and placebo, respectively ... Headache, upper respiratory tract infection, nasopharyngitis, and nausea were the most commonly reported adverse events in the adult RA clinical studies.
Edit

Karyopharm Reports Strong Third Quarter 2021 Financial Results and Provides Business Highlights

Daily Times Chronicle 03 Nov 2021
Adverse ReactionsThe most common adverse reactions (≥20%) in patients with multiple myeloma who receive XVd are fatigue, nausea, decreased appetite, diarrhea, peripheral neuropathy, upper respiratory tract infection, decreased weight, cataract and vomiting ... tract infection.
Edit

Zinc supplements ‘may cut how long respiratory infections last’

The Independent 02 Nov 2021
Respiratory tract infections (RTIs) can affect the sinuses, throat, airways or lungs, but most get better without treatment.
×